NCT05988242

Brief Summary

there is a scanty of researches which integrate to investigate the comparing effect of evening primrose oil and lavender as the essential oil that affects on menopausal vasomotor symptoms especially hot flashes and night sweet Therefore, the current study is expected to contribute to the knowledge and practice regarding the effect of lavender versus primrose oil on hot flashes and night sweat in menopausal women.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 20, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 21, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 20, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 20, 2023

Completed
25 days until next milestone

First Posted

Study publicly available on registry

August 14, 2023

Completed
Last Updated

August 15, 2023

Status Verified

August 1, 2023

Enrollment Period

1.1 years

First QC Date

July 20, 2023

Last Update Submit

August 11, 2023

Conditions

Keywords

Hot FlashesSweatMenopauseLavandulaPrimula

Outcome Measures

Primary Outcomes (3)

  • frequency of hot flashes among menopausal women.

    it will be assessed by Daily Hot Flash Diary: It is a selfreport dairy in which participants recorded how many hot flashes they experienced on a daily basis. Hot flashes throughout a 7-day period were added to produce a weekly hot flash frequency score

    Before intervention, 4 week after intervention, 8 week after intervention

  • severity of hot flashes among menopausal women

    it will be assessed by Daily Hot Flash Diaryas well as the severity of each hot flash on a scale of 1-3 (1 being mild, 2 moderate, and 3 severe). the number of hot flashes reported in each severity level was used to calculate the daily severity score, the total number of daily severity scores over the course of seven days was used to determine the hot flash severity index. The hot flash severity score for each day was calculated as the sum of the number of hot flashes within each severity category, multiplied by the severity score for that category, with the resulting sum divided by the total number of hot flashes

    Before intervention, 4 week after intervention, 8 week after intervention

  • to To what extent hot flash and night sweet are a problem

    This tool is standardized tool to measure the extent to which hot flash and night sweet are a problem, it is a subscale of the Hot Flush Rating Scale (HFRS) this validated self-report measure has three questions using 10-point Likert scales to rate the extent to which HFNS are problematic, distressing, and the cause of interference in daily life. Problem rating is calculated as the mean of the three questions, with higher scores indicating more problematic

    Before intervention, 4 week after intervention, 8 week after intervention

Secondary Outcomes (1)

  • Hot Flash Related Daily Interference

    Before intervention, 4 week after intervention, 8 week after intervention

Study Arms (3)

primrose oil

EXPERIMENTAL

primrose oil

Other: Primrose oil

lavender oil

EXPERIMENTAL

lavender oil

Other: Lavender oil

the placebo group

PLACEBO COMPARATOR

took the same bottle of oil which didn't contain the active substances but have the same shape, same oder, same color.

Other: placcebo

Interventions

group A will take primrose oil

primrose oil

group B will take lavender oil

lavender oil

this is the comparator group who will take the same bottle of oil which dosnt contain the active substances but have the sampe shape, same oder, same color

the placebo group

Eligibility Criteria

Age40 Years - 65 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • can read and write
  • experienced amenorrhea for \> 6 months
  • mild or moderate-to-severe hot flashes at least twice daily
  • normal blood pressure
  • normal kidney and liver function
  • no abnormal vaginal bleeding
  • no sensitivity to herbal substances

You may not qualify if:

  • Women with serious disease such as kidney, liver, seizure and allerg
  • use of hormonal medications or herbal treatment in the preceding 2 months for treatment of hot flushes or night sweet

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of nursinf

Cairo, 12519, Egypt

Location

Related Publications (9)

  • Kazemi F, Masoumi SZ, Shayan A, Oshvandi K. The Effect of Evening Primrose Oil Capsule on Hot Flashes and Night Sweats in Postmenopausal Women: A Single-Blind Randomized Controlled Trial. J Menopausal Med. 2021 Apr;27(1):8-14. doi: 10.6118/jmm.20033.

    PMID: 33942584BACKGROUND
  • Farzaneh F, Fatehi S, Sohrabi MR, Alizadeh K. The effect of oral evening primrose oil on menopausal hot flashes: a randomized clinical trial. Arch Gynecol Obstet. 2013 Nov;288(5):1075-9. doi: 10.1007/s00404-013-2852-6. Epub 2013 Apr 27.

    PMID: 23625331BACKGROUND
  • Reddi KK. Human granulocyte ribonuclease. Biochem Biophys Res Commun. 1976 Feb 23;68(4):1119-25. doi: 10.1016/0006-291x(76)90312-0. No abstract available.

    PMID: 5077BACKGROUND
  • Baker FC, Lampio L, Saaresranta T, Polo-Kantola P. Sleep and Sleep Disorders in the Menopausal Transition. Sleep Med Clin. 2018 Sep;13(3):443-456. doi: 10.1016/j.jsmc.2018.04.011.

    PMID: 30098758BACKGROUND
  • Carreiras M, Seghier ML, Baquero S, Estevez A, Lozano A, Devlin JT, Price CJ. An anatomical signature for literacy. Nature. 2009 Oct 15;461(7266):983-6. doi: 10.1038/nature08461.

    PMID: 19829380BACKGROUND
  • Mehrpooya M, Rabiee S, Larki-Harchegani A, Fallahian AM, Moradi A, Ataei S, Javad MT. A comparative study on the effect of "black cohosh" and "evening primrose oil" on menopausal hot flashes. J Educ Health Promot. 2018 Mar 1;7:36. doi: 10.4103/jehp.jehp_81_17. eCollection 2018.

    PMID: 29619387BACKGROUND
  • Green MR, Pastewka JV. The cationic carbocyanine dyes Stains-all DBTC, and Ethyl-Stains-all, DBTC-3,3',9 triethyl. J Histochem Cytochem. 1979 Mar;27(3):797-9. doi: 10.1177/27.3.90067.

    PMID: 90067BACKGROUND
  • Tsai J, Chung YC, Chen FP, Yeh ML. [Effect of Aromatherapy on Menopausal Symptoms, Heart Rate Variability, and Sleep Quality in Women]. Hu Li Za Zhi. 2020 Feb;67(1):44-54. doi: 10.6224/JN.202002_67(1).07. Chinese.

  • Kazemzadeh R, Nikjou R, Rostamnegad M, Norouzi H. Effect of lavender aromatherapy on menopause hot flushing: A crossover randomized clinical trial. J Chin Med Assoc. 2016 Sep;79(9):489-92. doi: 10.1016/j.jcma.2016.01.020. Epub 2016 Jul 4.

MeSH Terms

Conditions

Hot Flashes

Interventions

evening primrose oillavender oil

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Lamiaa Saad, lecturer

    faculty of nursing

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Regarding the nature of the intervention it will be double blind as the women will not know which intervention will take and the randomization of the groups will be done by person other than the researchers.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Parallel randomized controlled trial will be used to fulfill the aim of proposed study. The randomized control trial (RCT) is a trial in which subjects are randomly assigned to one of two or more groups: the intervention (group A) who will receive evening primrose oil, the intervention (group B) who will receive lavender oil, the third group ( C) who will receive placebo (Spieth et al, 2016).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of maternal and newborn health nursing

Study Record Dates

First Submitted

July 20, 2023

First Posted

August 14, 2023

Study Start

March 20, 2022

Primary Completion

April 21, 2023

Study Completion

July 20, 2023

Last Updated

August 15, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will share

the data will be shared online

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
four month
Access Criteria
will be published on magazine

Locations